Search - tctmd.com

Displaying 1 - 20 of 32

Sort: Relevancy | Date

News Industry News

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

July 16, 2019

News Industry News

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

June 24, 2019

News Industry News

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

May 06, 2019

News Industry News

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

April 17, 2019

News Industry News

Essential Medical Announces Positive Results from The Safe Manta Clinical Trial, The First Pivotal Trial for a Dedicated Large Bore Closure Device

June 25, 2018

News Industry News

Edwards Receives Approval For SAPIEN 3 Heart Valve In Canada

July 28, 2016

News Industry News

Essential Medical Inc. Announces FDA Approval to Begin a U.S. Clinical Trial for the MANTA™ Large Bore Vascular Closure Device

July 08, 2016

News Industry News

Cardiome Announces the Launch of ESMOCARD Solution for Injection in France

May 12, 2016

News Industry News

AV Medical Announces Successful Completion of 30 Patient Study with its Innovative Angioplasty Balloon Catheter, Chameleon™

April 22, 2016

News Industry News

Real-World Study Shows 72 Percent of Atrial Fibrillation Would Have Gone Undiagnosed in Stroke Patients if Cardiac Monitoring Had Been Limited to 30 Days

April 20, 2016

News Industry News

Cardiome Announces Filing of Orphan Drug Application for Oral Vernakalant with U.S. FDA

January 26, 2016

News Industry News

Cardiome Announces the Launch of ESMOCARD LYO in Belgium

January 20, 2016

News Industry News

Neovasc Receives FDA Approval to add 40mm Valve Size to the TIARA-I Clinical Trial

January 10, 2016

News Industry News

Cardiome Files New Drug Submission Seeking Canadian Approval of intravenous vernakalant

December 22, 2015

News Industry News

Neovasc Tiara™ Featured in Live Case Session at TCT 2015 Scientific Symposium

October 16, 2015

News Industry News

Edwards SAPIEN XT Valve Receives FDA Approval For Aortic Valve-In-Valve Procedures

October 15, 2015

News Industry News

ISIS Pharmaceuticals Reports Data from ISIS-TTR Rx in patients with Transthyretin Amyloid-Related Cardiomyopathy

July 27, 2015

News Industry News

Essential Medical Inc. Announces Successful Commencement of EU Studies for MANTA™ Large Bore Vascular Closure Device

July 27, 2015

News Industry News

Cardiome Partner Eddingpharm to Initiate BRINAVESS Phase I Study in China

July 24, 2015

News Industry News

Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada

July 22, 2015

Advertisement

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

Essential Medical Announces Positive Results from The Safe Manta Clinical Trial, The First Pivotal Trial for a Dedicated Large Bore Closure Device

Edwards Receives Approval For SAPIEN 3 Heart Valve In Canada

Essential Medical Inc. Announces FDA Approval to Begin a U.S. Clinical Trial for the MANTA™ Large Bore Vascular Closure Device

Cardiome Announces the Launch of ESMOCARD Solution for Injection in France

AV Medical Announces Successful Completion of 30 Patient Study with its Innovative Angioplasty Balloon Catheter, Chameleon™

Real-World Study Shows 72 Percent of Atrial Fibrillation Would Have Gone Undiagnosed in Stroke Patients if Cardiac Monitoring Had Been Limited to 30 Days

Cardiome Announces Filing of Orphan Drug Application for Oral Vernakalant with U.S. FDA

Cardiome Announces the Launch of ESMOCARD LYO in Belgium

Neovasc Receives FDA Approval to add 40mm Valve Size to the TIARA-I Clinical Trial

Cardiome Files New Drug Submission Seeking Canadian Approval of intravenous vernakalant

Neovasc Tiara™ Featured in Live Case Session at TCT 2015 Scientific Symposium

Edwards SAPIEN XT Valve Receives FDA Approval For Aortic Valve-In-Valve Procedures

ISIS Pharmaceuticals Reports Data from ISIS-TTR Rx in patients with Transthyretin Amyloid-Related Cardiomyopathy

Essential Medical Inc. Announces Successful Commencement of EU Studies for MANTA™ Large Bore Vascular Closure Device

Cardiome Partner Eddingpharm to Initiate BRINAVESS Phase I Study in China

Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content